TScan Therapeutics, Inc. (TCRX)
0.2377
+0.03
(+12.87%)
USD |
NASDAQ |
Oct 15, 16:00
0.2377
0.00 (0.00%)
After-Hours: 20:00
TScan Therapeutics Net Income (Quarterly) : -30.36M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -30.36M |
| March 31, 2026 | -28.67M |
| December 31, 2025 | -22.98M |
| September 30, 2025 | -35.71M |
| June 30, 2025 | -36.95M |
| March 31, 2025 | -34.13M |
| December 31, 2024 | -35.81M |
| September 30, 2024 | -29.89M |
| June 30, 2024 | -31.66M |
| March 31, 2024 | -30.14M |
| December 31, 2023 | -19.61M |
| September 30, 2023 | -23.00M |
| Date | Value |
|---|---|
| June 30, 2023 | -24.04M |
| March 31, 2023 | -22.56M |
| December 31, 2022 | -18.72M |
| September 30, 2022 | -16.24M |
| June 30, 2022 | -15.10M |
| March 31, 2022 | -16.16M |
| December 31, 2021 | -14.20M |
| September 30, 2021 | -15.84M |
| June 30, 2021 | -10.67M |
| March 31, 2021 | -7.912M |
| June 30, 2020 | -5.613M |
| March 31, 2020 | -5.537M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Agenus, Inc. | -0.567M |
| Amgen, Inc. | 2.375B |
| Anika Therapeutics, Inc. | 3.309M |
| BioCryst Pharmaceuticals, Inc. | 78.40M |
| Imunon, Inc. | -2.814M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 1.051M |
| Total Expenses (Quarterly) | 31.41M |
| EPS Diluted (Quarterly) | -0.2336 |
| Enterprise Value | 5.011M |
| Gross Profit Margin (Quarterly) | 33.49% |
| Profit Margin (Quarterly) | -2.89K% |
| Earnings Yield | -381.2% |
| Normalized Earnings Yield | -381.28 |